Related Experiment Videos
Can PK/PD be used in everyday clinical practice
1Department of Pharmacology, Toxicology and Chemotherapy, Faculty of Medicine, University of Milan, Via Vanvitelli 32, 20129 Milan, Italy. francesco.scaglione@unimi.it
International Journal of Antimicrobial Agents
|April 30, 2002
Summary
Optimizing antimicrobial dosing using pharmacokinetic-pharmacodynamic (PK/PD) relationships improves bacterial eradication and clinical outcomes. This approach personalizes therapy, leading to enhanced efficacy and reduced healthcare costs.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Established pharmacokinetic-pharmacodynamic (PK/PD) relationships link antimicrobial dosing to treatment success.
- Individualizing antimicrobial therapy requires understanding patient-specific PK parameters and pathogen MICs.
Purpose of the Study:
- To implement a hospital program utilizing PK/PD principles for antimicrobial therapy optimization.
- To evaluate the impact of individualized dosing on antimicrobial efficacy and healthcare costs.
Main Methods:
- Utilizing known or estimated pharmacokinetic parameters of antimicrobials.
- Incorporating the minimum inhibitory concentration (MIC) of the causative microorganism.
- Applying PK/PD models to guide antimicrobial dose adjustments.
Main Results:
- Preliminary data indicate that dose optimization enhances clinical efficacy.
- The approach suggests a potential for reducing overall treatment costs.
- Improved bacterial eradication rates are anticipated with tailored dosing.
Conclusions:
- Pharmacokinetic-pharmacodynamic (PK/PD) relationships are valuable tools for personalized antimicrobial therapy.
- Hospital-wide implementation of PK/PD-guided dosing shows promise for improving patient outcomes and cost-effectiveness.